Page last updated: 2024-09-03

almotriptan and Abdominal Migraine

almotriptan has been researched along with Abdominal Migraine in 130 studies

Research

Studies (130)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	107 (82.31)	29.6817
2010's	22 (16.92)	24.3611
2020's	1 (0.77)	2.80

Authors

Authors	Studies
Amundsen, S; Fuskevåg, OM; Nordeng, H; Nordmo, E; Sager, G; Spigset, O	1
Pascual, J; Vila, C	1
Casolla, B; D'Alonzo, L; Lionetto, L; Marsibilio, F; Martelletti, P; Negro, A; Simmaco, M; Vignaroli, G	1
Allais, G; Benedetto, C; Bussone, G; Omboni, S; Pezzola, D; Tullo, V; Zava, D	1
Allais, G; Barbanti, P; Benedetto, C; Bussone, G; Cortelli, P; Curone, M; Omboni, S; Peccarisi, C; Pezzola, D; Tullo, V; Zava, D	1
Evers, S	1
Han, W; Li, M; Wang, J; Xu, H	1
Defebvre, L; Destee, A; Gautier, S; Kreisler, A; Kwiatkowski, A; Lucas, C; Mazzoleni, R	1
De Klippel, N; Giurgea, S; Herroelen, L; Jacquy, J; Louis, P; Monseu, G; Schoenen, J; Vandenheede, M	1
Pascual, J	4
Goadsby, PJ	1
Dodick, DW	4
Biondi, DM; Cady, RK; Elkind, AH; Finlayson, G; Fisher, AC; Freitag, FG; Greenberg, SJ; Hulihan, JF; Mao, L; Mathew, NT	1
Burstein, R	1
Burstein, R; Jakubowski, M	1
Comas, A; Heras, J; Láinez, JM; Slof, J	1
Bigal, M; Hu, XH; Ng-Mak, DS	1
Bermejo, PE; Dorado, R; Gomez-Arguelles, JM	1
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP	1
Allena, M; Antonaci, F; Cuzzoni, MG; De Cillis, I	1
Armstrong, RB; Berenson, F; Biondi, DM; Mao, L; Pakalnis, A; Vasconcellos, E	1
Clissold, SP; Díaz-Insa, S; Lanteri-Minet, M; Leone, M; Vila, C	1
Acuto, G; Allais, G; Allais, R; Benedetto, C; Bussone, G; D'Andrea, G; d'Onofrio, F; Grazzi, L; Manzoni, GC; Moschiano, F; Valguarnera, F	1
Schoenen, J; Vandenheede, M	1
Leone, M; McGown, C; Vila, C	1
Lewis, DW	1
McGown, CC; Pascual, J; Vila, C	1
Díaz-Insa, S; McGown, CC; Vila, C	1
Díaz-Insa, S; Falqués, M; Fortea, J; Goadsby, PJ; Vila, C; Zanchin, G	1
Slof, J	1
Fox, AW; Oberhardt, F	1
Allaf, B; Lantéri-Minet, M; Lucas, C; Mekiès, C; Romatet, S	1
Bartolini, M; Brighina, F; Ferrari, MD; Fierro, B; Giamberardino, MA; Lisotto, C; Martelletti, P; Moscato, D; Omboni, S; Panascia, B; Pini, LA; Sances, G; Santoro, P; Savi, L; Zanchin, G	1
Candela, S; Casolla, B; D'Alonzo, L; Lionetto, L; Martelletti, P; Negro, A; Simmaco, M	1
Rapoport, AM; Sheftell, FD; Tepper, SJ	1
Csiba, L; Ficzere, A	1
Cabarrocas, X; Dowson, AJ; Laínez, JM; Massiou, H	2
Cabarrocas, X; Gras, J; Jansat, JM; Jáuregui, J; Llenas, J; Palacios, JM	1
Balbisi, EA	1
Costa, J; Fernandez, FJ; Jansat, JM; Martinez-Tobed, A; Salvà, P	1
Adelman, JU; Lewit, EJ	1
Mondell, BE	1
Reeder, CE; Williams, P	1
Azie, NE; Baldwin, JR; Carel, BJ; Fleishaker, JC	1
Dodick, DW; Ferrari, MD; Goadsby, PJ; McCrory, DC; Williams, P	1
López-Gil, A	1
Kowa, H; Nakashima, K; Takeshima, T	1
Gallagher, R	1
Silberstein, SD	1
Gendolla, A	1
Láinez, M	1
Muñoz, P; Pascual, J	1
Galván Cervera, J; Martínez Eizaguirre, JM; Tranche Iparraguirre, S	1
Fleishaker, JC; McEnroe, JD	1
de Tommaso, M; Di Fruscolo, O; Guido, M; Lamberti, P; Libro, G; Livrea, P; Losito, L; Sardaro, M; Sciruicchio, V	1
Dowson, AJ	1
Mathew, NT	3
Beneke, M; Diener, HC; Gebert, I; Gendolla, A	1
Allais, G; Bussone, G; D'Amico, D; Melzi, P; Moschiano, F; Rigamonti, A; Schieroni, F	1
Diener, HC	2
Capuano, A; Di Trapani, G; Evangelista, M; Ferraro, D; Mei, D; Pierguidi, L; Vollono, C	1
Taéron, C	1
Dahlöf, CG; Mathew, N; Nappi, G; Sandrini, G	1
Diener, HC; Massiou, H; Pascual, J	1
Galván, J; Slof, J	1
Dahlöf, CG; Dodick, DW; Dowson, AJ; Pascual, J	1
Cabarrocas, X; Costa, J; Garcia, E; Jansat, JM; Martinez-Tobed, A	1
Charles, JA	1
Acuto, G; Allais, G; Benedetto, C; Bussone, G; Cabarrocas, X; Esbri, R	1
Allaf, B; Donnet, A; Lanteri-Minet, M; Massiou, H; Pradalier, A	1
Cunha, L; Dahlöf, CG; Diener, HC; Dowson, AJ; Färkkilä, M; Goadsby, PJ; Manzoni, GC; Massiou, H; Mateos, V; Pascual, J; Raets, I	1
Acuto, G; Caiola, F; Gori, S; Iudice, A; Morelli, N; Murri, L	1
Adelman, J; Cady, RK; Finlayson, G; Greenberg, SJ; Mao, L; Mathew, NT; Smith, TR; Wright, P	1
Díez, FI; Straube, A; Zanchin, G	1
Galván, J; Heras, J; Láinez, MJ; Vila, C	1
Armstrong, RB; Diamond, ML; Elkind, AH; Finlayson, G; Fisher, AC; Freitag, FG; Greenberg, SJ; Hulihan, JF; Rapoport, AM; Unger, JR	1
Diener, HC; Pascual, J	1
Ashcroft, DM; Chen, LC	1
Láinez, MJ	1
Busch, V; Jürgens, TP; Leinisch, E; May, A; Schmidt-Wilcke, T; Schuierer, G	1
Krishnan, H; Ravikumar, K; Singh, AN; Sridhar, B	1
Biondi, DM; Cady, RK; Diamond, ML; Finlayson, G; Greenberg, SJ; Mao, L; Wright, P	1
Biondi, D; Finlayson, G; Freitag, F; Greenberg, S; Mao, L; Mathew, N; Rupnow, M; Smith, T; Wright, P	1
Cady, RK; Finlayson, G; Ishkanian, G; Lewis, DW; Linder, SL; Mathew, NT	1
Azie, NE; Carel, BJ; Fleishaker, JC; Sisson, TA	2
Deleu, D; Hanssens, Y	1
Docekal, P; Falk, RM; Ferrer, P; Luria, X; Pascual, J; Piessens, F; Prusinski, A; Robert, M; Segarra, R; Zayas, JM	1
Beleta, J; Bou, J; Domènech, T; Fernández-Forner, D; Gras, J; Heredia, A; Palacios, JM; Puig, J	1
Bou, J; Fernández, AG; Gras, J; Llenas, J; Palacios, JM	1
Cardelús, I; Gras, J; Llenas, J; Palacios, JM	1
Cabarrocas, X; Esbri, R; Ferrer, P; Peris, F	1
Brod, MI; Colman, SS; Gomez-Mancilla, B; Jirgens, KJ; Krishnamurthy, A; Rowland, CR	1
Cull, R	1
Cabarrocas, X; Docekal, R; Falk, R; Ferrer, P; Jelencsik, J; Luria, X; Pascual, J; Prusinski, A; Segarra, X	1
Hashimoto, S; Iwata, M	1
Azie, NE; Bell, DJ; Burke, MT; Carel, BJ; Fleishaker, JC; Jansat, JM; Ryan, KK	1
Marcus, DA	1
Gras, J; Llenas, J; Llupià, J; Palacios, JM	1
Dahlöf, C; Fazekas, A; Massiou, H; Tfelt-Hansen, P	1
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI	1
Bou, J; Cortijo, J; Gras, J; Llenas, J; Morcillo, EJ; Palacios, JM	1
Cabarrocas, X	1
Figgitt, DP; Goa, KL; Keam, SJ	2
Barr, CE; Goldfarb, SD; Rowland, CR; Torigoe, Y; Wang, E; Wang, JT	1
Von, S	1
Mayo, KW; Osterhaus, JT	1
Adelman, JU; Goldfarb, SD; Kozma, CM; Mannix, LK; Von, S	1
Freitag, FG	1
Tfelt-Hansen, P	1
Palmer, JB; Salonen, R	1
Cates, C	1
Cady, R	1
Barr, CE; Goldfarb, SD; Wang, JT	1
Cabarrocas, X; Pascual, J	1
Dahlöf, CG; Dodick, D; Dowson, AJ; Pascual, J	1

Reviews

51 review(s) available for almotriptan and Abdominal Migraine

Article	Year
Almotriptan: a review of 20 years' clinical experience. Expert review of neurotherapeutics, 2019, Volume: 19, Issue:8 Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2019
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34 Suppl 1 Topics: Carbazoles; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Migraine Disorders; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines	2013
The efficacy of triptans in childhood and adolescence migraine. Current pain and headache reports, 2013, Volume: 17, Issue:7 Topics: Adolescent; Analgesics; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Germany; Humans; Male; Migraine Disorders; Oxazolidinones; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2013
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. The journal of headache and pain, 2016, Volume: 17, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2016
Almotriptan in triptan-naïve patients: new evidence of benefits. Cephalalgia : an international journal of headache, 2008, Volume: 28 Suppl 2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Disease Management; Europe; Humans; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Prescriptions; Recurrence; Time Factors; Treatment Outcome; Tryptamines	2008
The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia : an international journal of headache, 2008, Volume: 28 Suppl 2 Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperalgesia; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Pain Measurement; Prospective Studies; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents	2008
Applying the benefits of the AwM study in the clinic. Cephalalgia : an international journal of headache, 2008, Volume: 28 Suppl 2 Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Patient Satisfaction; Patients; Physician-Patient Relations; Primary Health Care; Randomized Controlled Trials as Topic; Self Administration; Serotonin Receptor Agonists; Tryptamines; Vasoconstrictor Agents	2008
Almotriptan for the treatment of acute migraine: a review of early intervention trials. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:3 Topics: Acute Disease; Clinical Trials as Topic; Disability Evaluation; Humans; Migraine Disorders; Pain Measurement; Serotonin Receptor Agonists; Tryptamines	2010
Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:9 Topics: Acute Disease; Europe; Humans; Migraine Disorders; Primary Health Care; Serotonin Receptor Agonists; Tryptamines	2010
Almotriptan for the acute treatment of adolescent migraine. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:14 Topics: Adolescent; Humans; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2010
Almotriptan: a review of 10 years' clinical experience. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:10 Topics: Dose-Response Relationship, Drug; Early Diagnosis; Female; Humans; Male; Migraine Disorders; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2010
Improved patient satisfaction and pain evolution with almotriptan in migraine: a primary care study. Current medical research and opinion, 2011, Volume: 27, Issue:3 Topics: Analgesics; Chemoprevention; Disease Progression; Humans; Migraine Disorders; Pain; Patient Satisfaction; Primary Health Care; Prognosis; Tryptamines	2011
Treatment of perimenstrual migraine with triptans: an update. Current pain and headache reports, 2012, Volume: 16, Issue:5 Topics: Female; Humans; Migraine Disorders; Premenstrual Syndrome; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Tryptamines	2012
Mechanisms of action of the 5-HT1B/1D receptor agonists. Archives of neurology, 2002, Volume: 59, Issue:7 Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2002
[Treatment of migraine in patients with hypertension and ischemic heart disease]. Ideggyogyaszati szemle, 2002, Jan-20, Volume: 55, Issue:1-2 Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents	2002
Almotriptan, a new anti-migraine agent: a review. CNS drug reviews, 2002,Fall, Volume: 8, Issue:3 Topics: Animals; Area Under Curve; Cardiovascular System; Central Nervous System; Dose-Response Relationship, Drug; Humans; Indoles; Kidney; Migraine Disorders; Receptors, Serotonin; Respiratory System; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002
Efficacy and safety of almotriptan malate for migraine. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Nov-15, Volume: 59, Issue:22 Topics: Biological Availability; Clinical Trials as Topic; Drug Costs; Drug Interactions; Humans; Indoles; Migraine Disorders; Product Surveillance, Postmarketing; Serotonin Receptor Agonists; Tryptamines	2002
Almotriptan: pharmacological differences and clinical results. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Administration, Oral; Humans; Indoles; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2001
Comparative aspects of triptans in treating migraine. Clinical cornerstone, 2001, Volume: 4, Issue:3 Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2001
A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine. Clinical therapeutics, 2003, Volume: 25, Issue:2 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2003
A review of the clinical efficacy and tolerability of almotriptan in acute migraine. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:7 Topics: Acute Disease; Adult; Aged; Area Under Curve; Biological Availability; Female; Half-Life; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2003
Almotriptan: an effective and well-tolerated treatment for migraine pain. Drugs of today (Barcelona, Spain : 1998), 2003, Volume: 39 Suppl D Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2003
[Meta-analysis of triptan treatment in migraine]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9 Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2004
What do patients want from acute migraine treatment? Cephalalgia : an international journal of headache, 2004, Volume: 24 Suppl 2 Topics: Acute Disease; Analgesics; Attitude to Health; Clinical Trials as Topic; Disease Progression; Humans; Indoles; Migraine Disorders; Patient Acceptance of Health Care; Patient Satisfaction; Practice Patterns, Physicians'; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2004
Migraine pathophysiology and its clinical implications. Cephalalgia : an international journal of headache, 2004, Volume: 24 Suppl 2 Topics: Animals; Brain; Brain Stem; Cerebrovascular Circulation; Humans; Indoles; Migraine Disorders; Models, Neurological; Neural Pathways; Neurons; Nociceptors; Serotonin Receptor Agonists; Tryptamines	2004
Clinical profile and practice experience of almotriptan. Cephalalgia : an international journal of headache, 2004, Volume: 24 Suppl 2 Topics: Acute Disease; Analgesics; Attitude to Health; Clinical Trials as Topic; Disease Progression; Humans; Indoles; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2004
Clinical benefits of early triptan therapy for migraine. Cephalalgia : an international journal of headache, 2004, Volume: 24 Suppl 2 Topics: Acute Disease; Analgesics; Attitude to Health; Clinical Trials as Topic; Disease Progression; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2004
Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine. Clinical pharmacokinetics, 2005, Volume: 44, Issue:3 Topics: Adolescent; Aging; Animals; Biotransformation; Female; Food-Drug Interactions; Humans; Indoles; Kidney Diseases; Liver Diseases; Male; Migraine Disorders; Receptor, Serotonin, 5-HT1B; Serotonin Receptor Agonists; Sex Characteristics; Tissue Distribution; Tryptamines	2005
Oral almotriptan: practical uses in the acute treatment of migraine. Expert review of neurotherapeutics, 2004, Volume: 4, Issue:3 Topics: Acute Disease; Administration, Oral; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2004
Efficacy and tolerability of almotriptan in controlled clinical trials. European neurology, 2005, Volume: 53 Suppl 1 Topics: Humans; Indoles; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2005
Efficacy and tolerability of almotriptan in postmarketing surveillance studies. European neurology, 2005, Volume: 53 Suppl 1 Topics: Germany; Humans; Indoles; Migraine Disorders; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Spain; Treatment Outcome; Tryptamines	2005
Early triptan intervention in migraine: an overview. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2005, Volume: 26 Suppl 2 Topics: Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Tryptamines	2005
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine. International journal of clinical practice, 2005, Volume: 59, Issue:11 Topics: Acute Disease; Humans; Migraine Disorders; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2005
Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials. Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:4 Topics: Acute Disease; Dose-Response Relationship, Drug; Double-Blind Method; Headache; Humans; Migraine Disorders; Pain Measurement; Placebo Effect; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2006
Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine. Headache, 2007, Volume: 47, Issue:8 Topics: Confidence Intervals; Databases, Bibliographic; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2007
Almotriptan: meeting today's needs in acute migraine treatment. Expert review of neurotherapeutics, 2007, Volume: 7, Issue:12 Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2007
Current and emerging second-generation triptans in acute migraine therapy: a comparative review. Journal of clinical pharmacology, 2000, Volume: 40, Issue:7 Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines	2000
Almotriptan: a balanced approach to migraine. Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:2 Topics: Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indoles; Male; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2001
Oral almotriptan in the treatment of migraine: safety and tolerability. Headache, 2001, Volume: 41, Issue:5 Topics: Administration, Oral; Adult; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; Humans; Indoles; Male; Meta-Analysis as Topic; Middle Aged; Migraine Disorders; Safety; Serotonin Receptor Agonists; Tryptamines	2001
[Current topics: expectation for new triptans]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Apr-10, Volume: 90, Issue:4 Topics: Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2001
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Archives of neurology, 2001, Volume: 58, Issue:7 Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294 Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines	2001
Almotriptan: a review of its use in migraine. Drugs, 2002, Volume: 62, Issue:2 Topics: Animals; Drug Interactions; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2002
Almotriptan: a review of pharmacology, clinical efficacy, and tolerability. The American journal of managed care, 2002, Volume: 8, Issue:3 Suppl Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Indoles; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines; United States	2002
Health outcomes evaluations: estimating the impact of almotriptan in managed care settings. The American journal of managed care, 2002, Volume: 8, Issue:3 Suppl Topics: Cost Control; Drug Costs; Humans; Indoles; Managed Care Programs; Migraine Disorders; Outcome Assessment, Health Care; Patient Satisfaction; Quality of Life; Serotonin Receptor Agonists; Tryptamines; United States	2002
Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms. The American journal of managed care, 2002, Volume: 8, Issue:3 Suppl Topics: Chest Pain; Drug Costs; Electrocardiography; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; United States	2002
Acute treatment of migraine and the role of triptans. Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2 Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents	2001
Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis. Headache, 2002, Volume: 42 Suppl 1 Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Photophobia; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vomiting	2002
Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials. Headache, 2002, Volume: 42 Suppl 1 Topics: Acute Disease; Administration, Oral; Adult; Aged; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines	2002
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials. Headache, 2002, Volume: 42, Issue:2 Topics: Humans; Indoles; Migraine Disorders; Placebos; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2002
Spotlight on almotriptan in migraine. CNS drugs, 2002, Volume: 16, Issue:7 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002

Trials

46 trial(s) available for almotriptan and Abdominal Migraine

Article	Year
Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia. Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:10 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Physical Stimulation; Pilot Projects; Prevalence; Serotonin Receptor Agonists; Somatosensory Disorders; Treatment Outcome; Tryptamines	2008
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention. Headache, 2009, Volume: 49, Issue:3 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Hyperesthesia; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pain Threshold; Retrospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines; Young Adult	2009
Migraine treatment with rizatriptan and almotriptan: a crossover study. Headache, 2009, Volume: 49, Issue:5 Topics: Adult; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Proportional Hazards Models; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2009
Variation in almotriptan effectiveness according to different prophylactic treatments. Headache, 2009, Volume: 49, Issue:9 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Calcium Channel Blockers; Drug Interactions; Drug Therapy, Combination; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Propranolol; Serotonin Receptor Agonists; Topiramate; Treatment Outcome; Tryptamines; Young Adult	2009
Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache, 2010, Volume: 50, Issue:5 Topics: Acute Disease; Administration, Oral; Adolescent; Child; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Tryptamines	2010
Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study. International journal of clinical practice, 2010, Volume: 64, Issue:7 Topics: Acute Disease; Adult; Analgesics; Disabled Persons; Female; Humans; Male; Migraine Disorders; Patient Education as Topic; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2010
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:2 Topics: Adolescent; Adult; Animals; Cross-Over Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Placebos; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Young Adult	2011
The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "Act when mild" study. The International journal of neuroscience, 2011, Volume: 121, Issue:12 Topics: Adult; Double-Blind Method; Female; Humans; Hyperalgesia; Male; Migraine Disorders; Pain; Pain Measurement; Prospective Studies; Time Factors; Treatment Outcome; Tryptamines	2011
Oral sumatriptan and almotriptan--delimiting the MAOI effect. Headache, 2012, Volume: 52, Issue:5 Topics: Administration, Oral; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Migraine Disorders; Models, Biological; Monoamine Oxidase; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Time Factors; Tryptamines	2012
Stability, responsiveness, and reproducibility of a visual analog scale for treatment satisfaction in migraine. Headache, 2012, Volume: 52, Issue:6 Topics: Adult; Analgesics; Female; Humans; Male; Migraine Disorders; Patient Satisfaction; Reproducibility of Results; Tryptamines	2012
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study. The journal of headache and pain, 2012, Volume: 13, Issue:5 Topics: Adult; Carbazoles; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Proportional Hazards Models; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Tryptamines	2012
Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002
Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers. Journal of clinical pharmacology, 2002, Volume: 42, Issue:12 Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Half-Life; Humans; Indoles; Infusions, Intravenous; Injections, Subcutaneous; Male; Migraine Disorders; Models, Biological; Serotonin Receptor Agonists; Time Factors; Tryptamines	2002
A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults. Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:4 Topics: Adolescent; Adult; Age Factors; Area Under Curve; Child; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Indoles; Male; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2004
Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Headache, 2004, Volume: 44, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines	2004
[Tolerance to almotriptan and its effectiveness in primary care]. Atencion primaria, 2005, Volume: 35, Issue:1 Topics: Humans; Indoles; Migraine Disorders; Primary Health Care; Prospective Studies; Tryptamines	2005
Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack. Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:5 Topics: Adult; Aspirin; Evoked Potentials; Female; Hot Temperature; Humans; Hyperalgesia; Indoles; Lasers; Lysine; Middle Aged; Migraine Disorders; Tryptamines	2005
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. European neurology, 2005, Volume: 53 Suppl 1 Topics: Adolescent; Adult; Aged; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2005
Multiple attack study on the available triptans in Italy versus placebo. European journal of neurology, 2005, Volume: 12, Issue:7 Topics: Adult; Female; Humans; Indoles; Italy; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2005
Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Current medical research and opinion, 2005, Volume: 21, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2005
Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial. International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:4 Topics: Administration, Oral; Adult; Biological Availability; Cross-Over Studies; Eating; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2006
Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. The journal of headache and pain, 2006, Volume: 7, Issue:2 Topics: Adolescent; Child; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Female; Humans; Male; Migraine Disorders; Pain Measurement; Pilot Projects; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2006
Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2006, Volume: 27 Suppl 2 Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2006
Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study. European neurology, 2006, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Female; France; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Safety; Self-Assessment; Serotonin Receptor Agonists; Surveys and Questionnaires; Tryptamines	2006
Almotriptan and zolmitriptan in the acute treatment of migraine. Acta neurologica Scandinavica, 2007, Volume: 115, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Headache, 2007, Volume: 47, Issue:2 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Early Diagnosis; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; United States	2007
Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan. Journal of neurology, 2007, Volume: 254, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Single-Blind Method; Time Factors; Triazoles; Tryptamines	2007
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. European journal of neurology, 2007, Volume: 14, Issue:3 Topics: Acute Disease; Adult; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Migraine Disorders; Nausea; Patient Satisfaction; Phosphodiesterase Inhibitors; Photophobia; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents	2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache, 2007, Volume: 47, Issue:4 Topics: Adolescent; Adult; Aged; Cluster Analysis; Double-Blind Method; Early Diagnosis; Female; Humans; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Tryptamines	2007
Use of almotriptan in triptan-experienced and triptan-naïve patients. Current medical research and opinion, 2007, Volume: 23, Issue:10 Topics: Humans; Migraine Disorders; Patient Satisfaction; Placebos; Serotonin Receptor Agonists; Tryptamines	2007
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache, 2008, Volume: 48, Issue:2 Topics: Adolescent; Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Menstruation; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2008
Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial. Headache, 2008, Volume: 48, Issue:3 Topics: Adult; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Placebos; Quality of Life; Serotonin Receptor Agonists; Time; Tryptamines	2008
Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache, 2008, Volume: 48, Issue:9 Topics: Adolescent; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Migraine Disorders; Placebos; Serotonin Receptor Agonists; Tryptamines	2008
Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers. Clinical pharmacology and therapeutics, 2000, Volume: 67, Issue:5 Topics: Adolescent; Adult; Analysis of Variance; Blood Pressure; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Drug Interactions; Electrocardiography; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Reference Values; Serotonin Receptor Agonists; Tablets; Tryptamines; Verapamil	2000
Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Molecular Structure; Myocardial Ischemia; Reproducibility of Results; Safety; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2000
Long-term efficacy and safety of oral almotriptan: interim analysis of a 1-year open study. Headache, 2001, Volume: 41, Issue:1 Topics: Adult; Aged; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2001
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan. Clinical therapeutics, 2001, Volume: 23, Issue:1 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Quality of Life; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2001
Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers. Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:1 Topics: Adolescent; Adult; Area Under Curve; Cross-Over Studies; Drug Interactions; Female; Half-Life; Humans; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Migraine Disorders; Propranolol; Reference Values; Serotonin Receptor Agonists; Tryptamines; Vasodilator Agents	2001
Tolerability and efficacy of almotriptan in the long-term treatment of migraine. European neurology, 2001, Volume: 45, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pain Measurement; Self Administration; Serotonin Receptor Agonists; Tablets; Time; Treatment Outcome; Tryptamines	2001
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans. British journal of clinical pharmacology, 2001, Volume: 51, Issue:5 Topics: Adolescent; Adult; Cross-Over Studies; Drug Interactions; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Serotonin Receptor Agonists; Tryptamines	2001
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine. Neurology, 2001, Nov-27, Volume: 57, Issue:10 Topics: Acute Disease; Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pain Measurement; Treatment Outcome; Tryptamines	2001
Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study. Clinical therapeutics, 2001, Volume: 23, Issue:11 Topics: Acute Disease; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2001
Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms. The American journal of managed care, 2002, Volume: 8, Issue:3 Suppl Topics: Chest Pain; Drug Costs; Electrocardiography; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; United States	2002
Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials. Headache, 2002, Volume: 42, Issue:1 Topics: Acute Disease; Adult; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Palliative Care; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002
Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache, 2002, Volume: 42, Issue:1 Topics: Administration, Oral; Adult; Drug Administration Schedule; Humans; Indoles; Longitudinal Studies; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine. Headache, 2002, Volume: 42, Issue:1 Topics: Acute Disease; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002

Other Studies

34 other study(ies) available for almotriptan and Abdominal Migraine

Article	Year
Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding. Basic & clinical pharmacology & toxicology, 2021, Volume: 128, Issue:6 Topics: Adult; Breast Feeding; Female; Humans; Infant; Infant, Newborn; Migraine Disorders; Milk, Human; Oxazolidinones; Piperidines; Pyrrolidines; Triazoles; Tryptamines	2021
Pharmacokinetic evaluation of almotriptan for the treatment of migraines. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:5 Topics: Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Tolerance; Humans; Migraine Disorders; Pain; Tryptamines	2013
Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34 Suppl 1 Topics: Carbazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Double-Blind Method; Female; Humans; Menstruation; Migraine Disorders; Multicenter Studies as Topic; Oxazolidinones; Premenstrual Syndrome; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines	2013
Seizure after use of almotriptan. Clinical neurology and neurosurgery, 2008, Volume: 110, Issue:8 Topics: Calcium Channels; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Migraine Disorders; Mutation; Paresis; Positron-Emission Tomography; Seizures; Sodium-Potassium-Exchanging ATPase; Tryptamines	2008
Almotriptan efficacy in migraine with developing allodynia is as high as the efficacy in migraine without allodynia--but is it the same in migraine with established allodynia? Headache, 2009, Volume: 49, Issue:3 Topics: Humans; Hyperalgesia; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2009
Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al. Cephalalgia : an international journal of headache, 2009, Volume: 29, Issue:10 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Physical Stimulation; Pilot Projects; Prevalence; Serotonin Receptor Agonists; Somatosensory Disorders; Treatment Outcome; Tryptamines	2009
[Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis]. Neurologia (Barcelona, Spain), 2009, Volume: 24, Issue:3 Topics: Analgesics, Non-Narcotic; Caffeine; Cost-Benefit Analysis; Costs and Cost Analysis; Ergotamine; Health Care Costs; Humans; Migraine Disorders; Patient Satisfaction; Quality of Life; Treatment Outcome; Tryptamines	2009
Drug dependence associated with triptans and ergot derivatives: a case/non-case study. European journal of clinical pharmacology, 2010, Volume: 66, Issue:4 Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines	2010
Almotriptan efficacy in migraine with allodynia: a rebuttal to Burstein and Jakubowski's critique of Schoenen et al. Cephalalgia : an international journal of headache, 2010, Volume: 30, Issue:9 Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Somatosensory Disorders; Tryptamines	2010
Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study. Applied health economics and health policy, 2012, May-01, Volume: 10, Issue:3 Topics: Acute Disease; Cost-Benefit Analysis; Early Medical Intervention; France; Humans; Migraine Disorders; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines	2012
New medications show promise for migraine sufferers. Dentistry today, 2002, Volume: 21, Issue:10 Topics: Botulinum Toxins, Type A; Carbazoles; Humans; Indoles; Magnesium; Migraine Disorders; Neuromuscular Agents; Phytotherapy; Plant Preparations; Pyrrolidines; Riboflavin; Serotonin Antagonists; Tanacetum parthenium; Tryptamines	2002
Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine. Clinical therapeutics, 2003, Volume: 25, Issue:11 Topics: Acute Disease; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Care Costs; Health Services; Humans; Indoles; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines	2003
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. Acta neurologica Scandinavica, 2004, Volume: 110, Issue:3 Topics: Administration, Oral; Adult; Data Collection; Decision Support Techniques; Dose-Response Relationship, Drug; Female; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Patient Selection; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines	2004
Evaluating triptan usage: a rebuttal. Headache, 2004, Volume: 44, Issue:9 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines	2004
Correlation between lipophilicity and triptan outcomes. Headache, 2005, Volume: 45, Issue:1 Topics: Central Nervous System Diseases; Chemical Phenomena; Chemistry, Physical; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Statistics as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2005
Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice. Headache, 2005, Volume: 45, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2005
[Almotriptan. One more triptan for migraines]. Revue de l'infirmiere, 2004, Issue:102 Topics: Drug Monitoring; Humans; Indoles; Migraine Disorders; Patient Education as Topic; Patient Selection; Serotonin Receptor Agonists; Tryptamines	2004
Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example. The journal of headache and pain, 2006, Volume: 7, Issue:1 Topics: Humans; International Cooperation; Migraine Disorders; Pain Measurement; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2006
[Economic evaluation of acute migraine attack treatment with triptans in Spain]. Neurologia (Barcelona, Spain), 2006, Volume: 21, Issue:2 Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Spain; Treatment Outcome; Tryptamines	2006
A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy. Minerva medica, 2006, Volume: 97, Issue:6 Topics: Administration, Oral; Cost-Benefit Analysis; Decision Trees; Humans; Italy; Migraine Disorders; Sensitivity and Specificity; Triazoles; Tryptamines	2006
Migraine-like headache in intracranial haemorrhage is alleviated by sumatriptan and almotriptan. Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:3 Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Headache; Humans; Intracranial Hemorrhages; Male; Migraine Disorders; Sumatriptan; Tryptamines	2008
Almotriptan, an antimigraine agent, and its malate salt. Acta crystallographica. Section C, Crystal structure communications, 2008, Volume: 64, Issue:Pt 1 Topics: Crystallography, X-Ray; Hydrogen Bonding; Malates; Migraine Disorders; Molecular Conformation; Serotonin Receptor Agonists; Structure-Activity Relationship; Tryptamines	2008
Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine. European journal of pharmacology, 2000, Dec-20, Volume: 410, Issue:1 Topics: Animals; Cattle; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; HeLa Cells; Humans; Indoles; Male; Meningeal Arteries; Migraine Disorders; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Wistar; Saphenous Vein; Serotonin Receptor Agonists; Sumatriptan; Swine; Transfection; Tryptamines; Vasoconstriction; Vasoconstrictor Agents	2000
Functional profile of almotriptan in animal models predictive of antimigraine activity. European journal of pharmacology, 2000, Dec-20, Volume: 410, Issue:1 Topics: Animals; Arteriovenous Anastomosis; Carotid Arteries; Cats; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Female; Guinea Pigs; Hemodynamics; Indoles; Male; Meningeal Arteries; Migraine Disorders; Models, Animal; Muscle, Smooth, Vascular; Regional Blood Flow; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstriction; Vasodilation	2000
Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine. European journal of pharmacology, 2000, Dec-20, Volume: 410, Issue:1 Topics: Animals; Blood Pressure; Cardiovascular System; Cats; Coronary Circulation; Coronary Vessels; Dogs; Electrocardiography; Female; Guinea Pigs; Heart Rate; Indoles; Injections, Subcutaneous; Macaca fascicularis; Male; Migraine Disorders; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Safety; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2000
[Migraine headache. Severe attacks: triptans are essential]. MMW Fortschritte der Medizin, 2001, Jul-19, Volume: 143, Issue:28-29 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2001
Safety profile of almotriptan, a new antimigraine agent. Effects on central nervous system, renal function and respiratory dynamics. Arzneimittel-Forschung, 2001, Volume: 51, Issue:9 Topics: Animals; Behavior, Animal; Central Nervous System; Dogs; Drug Interactions; Guinea Pigs; Indoles; Kidney; Kidney Function Tests; Male; Mice; Migraine Disorders; Rats; Respiratory Mechanics; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2001
Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries. Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:8 Topics: Arteries; Basilar Artery; Carotid Artery, Internal; Coronary Vessels; Humans; In Vitro Techniques; Indoles; Meningeal Arteries; Migraine Disorders; Ophthalmic Artery; Pulmonary Veins; Serotonin Receptor Agonists; Sumatriptan; Temporal Arteries; Tryptamines; Vasoconstriction; Vasoconstrictor Agents	2001
Almotriptan (Axert) and frovatriptan (Frova) for migrane. The Medical letter on drugs and therapeutics, 2002, Feb-18, Volume: 44, Issue:1124 Topics: Adult; Carbazoles; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2002
Cost savings in migraine associated with less chest pain on new triptan therapy. The American journal of managed care, 2002, Volume: 8, Issue:3 Suppl Topics: Chest Pain; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Data Collection; Female; Humans; Indoles; Male; Migraine Disorders; Outcome Assessment, Health Care; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; United States	2002
Triptan medications to treat acute migraine. Lancet (London, England), 2002, Mar-30, Volume: 359, Issue:9312 Topics: Acute Disease; Clinical Trials as Topic; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2002
Triptan medications to treat acute migraine. Lancet (London, England), 2002, Mar-30, Volume: 359, Issue:9312 Topics: Acute Disease; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2002
Triptan medications to treat acute migraine. Lancet (London, England), 2002, Mar-30, Volume: 359, Issue:9312 Topics: Acute Disease; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2002
Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan. Headache, 2002, Volume: 42 Suppl 1 Topics: Adolescent; Adult; Chest Pain; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Drug Costs; Electrocardiography; Female; Health Care Costs; Humans; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002